Julian C. Baker

Julian C. Baker is recorded as Board Member at Acadia Pharmaceuticals Inc (ACAD), Board Member at Madrigal Pharmaceuticals, Inc. (MDGL) since April 22, 2026 and Chairman at Madrigal Pharmaceuticals, Inc. (MDGL). The newest filing on record that lists Julian C. Baker as Board Member at Acadia Pharmaceuticals Inc (ACAD) is dated April 24, 2026. The newest filing on record that lists Julian C. Baker as Chairman at Madrigal Pharmaceuticals, Inc. (MDGL) is dated April 28, 2026. Madrigal Pharmaceuticals, Inc. reported in an 8-K filed April 28, 2026 that Julian C. Baker was appointed Class I director, effective April 22, 2026. Madrigal Pharmaceuticals, Inc. reported in an 8-K filed April 28, 2026 that Julian C. Baker resigned as Class III director, effective April 22, 2026. Acadia Pharmaceuticals Inc reported in an 8-K filed May 29, 2024 that Julian C. Baker was appointed Class II director, effective May 29, 2024. Acadia Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Madrigal Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Acadia Pharmaceuticals Inc includes Catherine Owen Adams (CEO and Board Member), Stephen R. Biggar (Chairman and Board Member), Mark C. Schneyer (CFO) and 7 others.